Peri-implant Mucositis
Conditions
Keywords
ozonized water
Brief summary
The aim of this study is to assess if ozonized water can be used for the treatment of peri-implant mucositis in patients with dental implants. Patients willl undergo professional dental hygiene also with the use of glycine powders, then they will be randomly divided into two groups: * Trial Group: irrigation of peri-implant periodontium with mucositis with ozonized water. * Placebo Group: irrigation of peri-implant periodontium with mucositis with water. Periodontal indices will be recorded at the baseline, after 1 and 2 months. After 1 and 2 months, only glycine powders will be performed, together with ozonized water or water irrigation and the collection of periodontal indices.
Detailed description
The aim of this study is to assess if ozonized water can be used for the treatment of peri-implant mucositis in patients with dental implants. Patients who respond to eligibility criteria and that will sign the informed consent will undergo a professional oral hygiene procedure. Patients willl undergo professional dental hygiene also with the use of glycine powders. Then, glycine powders air-flow will be administered. Then they will be randomly divided into two groups: * Trial Group: irrigation of peri-implant periodontium with mucositis with ozonized water. * Placebo Group: irrigation of peri-implant periodontium with mucositis with water. Periodontal indices will be recorded at the baseline, after 1 and 2 months. After 1 and 2 months, only glycine powder will be performed, together with ozonized water/water irrigation and the collection of periodontal indices.
Interventions
OTHEROzonized water
Irrigation of dental implants with ozonized water
OTHERPlacebo
Irrigation of dental implants with water
Sponsors
University of Pavia
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Presence of one or more dental implants * Presence of peri-implant mucositis at least at one implant * Bleeding Score \> 0
Exclusion criteria
* Patents without dental implants * Presence of systemic diseases * Patients with cardiac pacemaker
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in PPD - Probing Depth | Baseline, 1 and 2 months. | Evaluation (in mm) of the depth of the gingival sulcus, through a millimeter periodontal probe; it is detected from the gingival margin to the bottom of the gingival sulcus of the peri-implant pocket, evaluated at 6 sites. |
| Change in BOP - Bleeding on Probing (percentage) | Baseline, 1 and 2 months. | Site-specific assessment of the presence or absence of gum bleeding after the insertion of the periodontal probe for the detection of PD, detected on 6 sites. |
| Change in BS - Bleeding Score | Baseline, 1 and 2 months. | Scoring criteria: * 0: no bleeding; * 1: punctiform bleeding in the site of probing; * 2: bleeding within the gingival border; * 3: bleeding outside the gingival border. |
| Change in PI - Plaque Index (percentage) | Baseline, 1 and 2 months. | Site-specific assessment of the presence or visible plaque detected on 4 sites with a disclosing tables. Percentage of sites with plaque determines the PI%. |
Countries
Italy
Outcome results
None listed